enVVeno Medical shares rise 10.01% after-hours after reporting Q2 2022 financial results and a corporate update.

enVVeno Medical surged 10.01% in after-hours trading following the release of its second-quarter 2022 financial results and a corporate update. The report, announced on August 3, likely included key metrics or strategic developments that reassured investors after a prior 71% intraday decline. While the summary highlights earlier volatility, the after-hours rally suggests the earnings update addressed market concerns, potentially through improved guidance, cost management, or product progress. The timing aligns with the news event, indicating the corporate update was the primary catalyst for the post-market rebound.